human
coronavirus
hcov
envelop
positivestrand
rna
virus
belong
famili
coronavirida
order
nidoviral
mostli
respons
upper
respiratori
tract
infect
opportunist
pathogen
also
associ
seriou
human
patholog
pneumonia
bronchiol
even
mening
vulner
popul
moreov
least
natur
neuroinvas
neurotrop
human
inde
previous
report
hcov
infect
persist
human
neural
cell
human
brain
moreov
strain
induc
enceph
suscept
mice
neuron
main
target
infect
envelop
virus
use
differ
type
protein
induc
fusion
hostcel
membran
order
initi
infect
coronavirus
spike
protein
respons
cell
entri
shown
major
factor
virul
central
nervou
system
cn
sever
coronaviru
speci
includ
previous
report
persist
infect
human
neural
cell
line
led
appear
predomin
point
mutat
put
receptorbind
domain
glycoprotein
gene
mutat
suffici
significantli
increas
neurovirul
modifi
neuropatholog
balbc
mice
order
identifi
amino
acid
residu
glycoprotein
involv
viral
spread
within
cn
compar
sequenc
gene
encod
viral
protein
laboratori
refer
strain
atcc
sequenc
gene
virus
detect
clinic
isol
sputum
upper
lower
respiratori
tract
seven
children
age
month
admit
univers
hospit
caen
franc
well
protein
sequenc
found
ncbi
data
bank
character
led
identif
predomin
mutat
includ
one
amino
acid
introduc
put
furinlik
proteas
cleavag
site
viral
protein
sever
class
viral
fusion
protein
coronaviru
protein
proteolyt
process
infect
host
cell
mechan
often
essenti
initi
infect
receptorbear
cell
tissu
tropism
eventu
pathogenesi
moreov
cleavag
differ
type
host
proteas
includ
furinlik
proteas
design
proprotein
convertas
pc
cleav
pair
basic
residu
involv
variou
step
coronaviru
infect
present
studi
show
first
time
glycoprotein
laboratori
refer
strain
atcc
cleav
host
cell
proteas
sequenc
clinic
isol
reveal
common
result
singl
nucleotid
polymorph
snp
gene
creat
function
pccleavag
site
portion
viral
glycoprotein
therebi
modul
viral
spread
neurovirul
suscept
mice
without
affect
neuroinvas
capac
viru
infect
capac
infect
neuron
cell
line
result
suggest
pccleavag
dispens
effici
infect
appear
surpris
compar
coronavirus
protein
cleavag
requir
effici
viru
infect
importantli
result
may
help
better
character
possibl
adapt
cn
environ
end
result
decreas
neurovirul
potenti
associ
modifi
spread
effici
mechan
establish
persist
infect
human
cn
phenomenon
could
influenc
sever
human
viral
enceph
exacerb
neurolog
degen
patholog
unknown
etiolog
first
sought
investig
potenti
biolog
function
viral
mutat
locat
gene
domain
detect
viral
protein
sever
clinic
isol
human
sputum
upper
lower
respiratori
tract
accordingli
introduc
mutat
infecti
cdna
clone
produc
recombin
mutat
viru
first
studi
neuroinvas
neurovirul
properti
compar
refer
rocatcc
viru
fig
dayold
balbc
mice
inocul
intranas
rout
surviv
curv
obtain
fig
infect
refer
viru
half
balbc
mice
die
within
first
day
postinfect
symptom
social
isol
hunch
back
comparison
viral
mutant
less
neurovirul
mortal
despit
differ
surviv
chang
symptom
induc
mutant
viru
compar
refer
strain
mice
also
investig
variat
weight
infect
fig
previous
describ
mice
infect
mutant
viru
show
delay
bodi
weight
gain
day
postinfect
compar
control
mice
comparison
surviv
curv
mice
infect
variant
coupl
weight
variat
suggest
variant
less
neurovirul
refer
viru
rocatcc
inocul
rout
determin
whether
slight
differ
neurovirul
two
virus
could
relat
differ
viral
replic
kinet
within
cn
brain
fig
spinal
cord
fig
harvest
infecti
viru
product
evalu
everi
day
period
day
postinfect
dpi
even
though
differ
neurovirul
two
virus
correl
differ
amount
product
infecti
viral
particl
cn
brain
spinal
cord
delay
viral
replic
kinet
mutant
viru
compar
refer
viru
viral
spread
mous
brain
fig
also
studi
focu
olfactori
bulb
hippocampu
region
previous
determin
region
primarili
infect
refer
viru
strain
dpi
viral
antigen
alreadi
present
everywher
olfactori
bulb
infect
refer
wildtyp
viru
fig
compar
mutant
viru
antigen
scarc
distribut
dpi
kinet
restor
mutant
infect
region
effici
refer
viru
hippocampu
observ
trend
viral
antigen
detect
region
mutant
viru
dpi
wherea
spread
virus
similar
dpi
fig
virus
spread
region
brain
activ
astrocyt
microgli
cell
evid
infect
region
fig
even
though
precis
quantit
perform
slight
increas
number
astrocyt
observ
olfactori
bulb
fig
hippocampu
fig
mice
infect
refer
viru
compar
mutant
viru
activ
microgli
cell
evid
hippocampu
region
variant
dpi
fig
mutant
viru
protein
harbor
snp
present
respiratori
clinic
isol
also
evalu
viral
dissemin
toward
respiratori
tract
neither
infecti
viru
particl
viral
rna
detect
lung
mice
test
demonstr
viru
variant
retain
neuroinvas
neurovirul
capac
mous
model
intranas
inocul
sought
studi
spread
neurovirul
capac
two
recombin
virus
intracerebr
ic
inocul
rout
result
reproduc
infect
associ
better
control
viral
dose
introduc
brain
order
dayold
femal
balbc
mice
use
experi
perform
character
mous
surviv
weight
curv
clinic
symptom
enceph
viral
replic
brain
spinal
cord
fig
signific
differ
surviv
inocul
either
viru
fig
mutant
viru
like
sham
control
induc
mortal
compar
refer
viru
led
mortal
rate
period
day
measur
weight
mice
infect
fig
observ
signific
delay
bodi
weight
gain
refer
viru
mutant
viru
compar
sham
control
dpi
correl
surviv
curv
use
clinic
score
scale
base
neurolog
symptom
mice
describ
materi
method
section
next
studi
clinic
symptom
mice
inject
variant
fig
clinic
sign
caus
mutant
viru
abnorm
flexion
four
limb
level
wherea
mice
infect
refer
viru
develop
enceph
associ
differ
level
clinic
score
clinic
sign
note
sham
mice
taken
togeth
surviv
weight
curv
coupl
clinic
score
indic
mutant
viru
less
neurovirul
refer
viru
ic
inocul
old
mice
given
observ
refer
viru
neurovirul
compar
mutant
viru
inocul
ic
rout
wish
evalu
whether
correl
differ
viral
replic
cn
brain
spinal
cord
harvest
infecti
viru
titer
assay
everi
day
period
dpi
fig
differ
neurovirul
correl
signific
differ
amount
infecti
viral
particl
brain
fig
howev
drastic
differ
product
infecti
viru
variant
spinal
cord
fig
viru
titer
refer
strain
rocatcc
almost
ident
detect
brain
wherea
less
virul
mutant
reach
spinal
cord
one
thirti
infect
mice
mous
import
delay
product
viral
infecti
particl
close
limit
detect
suggest
mutant
viru
difficulti
reach
portion
cn
histolog
examin
infect
mice
reveal
infect
region
similar
follow
infect
virus
brain
kinet
differ
fig
inde
case
rout
infect
ic
rout
infect
also
led
delay
viral
replic
olfactori
bulb
hippocampu
viral
antigen
detect
dpi
mutant
viru
compar
dpi
refer
viru
dayold
balbc
mice
infect
viru
spread
region
brain
activ
astrocyt
microgli
cell
evid
infect
region
fig
seen
dayold
mice
inocul
even
though
precis
quantit
perform
slight
increas
number
astrocyt
olfactori
bulb
fig
hippocampu
fig
could
observ
brain
mice
infect
refer
viru
compar
mutant
viru
observ
microgli
cell
dpi
olfactori
bulb
fig
hippocampu
fig
order
studi
role
mutat
biolog
variant
first
evalu
kinet
viral
replic
spread
within
mix
primari
cn
cultur
balbc
mice
period
h
postinfect
hpi
use
immunofluoresc
observ
chang
cell
tropism
neuron
remain
main
target
infect
viru
variant
fig
even
though
astrocyt
could
also
infect
later
infect
fig
previous
report
interestingli
observ
delay
viral
spread
neuron
mutant
viru
hpi
compar
refer
strain
fig
interestingli
even
though
infect
shown
product
variant
primari
cn
cultur
balbc
mice
signific
increas
total
amount
infecti
viru
cell
cultur
supernat
free
viru
hpi
mutant
viru
compar
refer
viru
rocatcc
fig
mutat
creat
put
furinlik
cleavag
site
glycoprotein
previous
report
influenc
viral
infect
wish
evalu
whether
cleavag
inde
associ
delay
spread
neuron
cell
increas
releas
infecti
viru
eventu
neurovirul
seen
fig
data
correl
much
stronger
cleavag
protein
mutant
fragment
compar
refer
viru
rocatcc
hpi
fig
whole
cell
lysat
even
obviou
hpi
cell
supernat
fig
order
evalu
whether
cleavag
viral
protein
also
took
place
human
cell
made
use
differenti
neuron
cell
line
describ
materi
method
section
show
first
kinet
viral
replic
similar
observ
virus
murin
primari
cell
fig
signific
increas
viru
releas
mutant
second
cleavag
protein
fragment
predominantli
detect
cell
cultur
supernat
fig
compar
protein
associ
cell
fig
cleavag
evid
mutant
refer
viru
similar
result
obtain
cell
even
though
protein
refer
viru
present
mostli
uncleav
form
result
also
show
intermedi
size
band
uncleav
furinlik
cleav
form
protein
secondari
band
may
unspecif
degrad
product
suggest
among
intermedi
size
fragment
seen
sdspage
could
fragment
correspond
protein
cleav
potenti
altern
site
fig
latter
show
correspond
overexposit
attempt
determin
whether
mutat
identifi
amino
acid
viral
protein
could
inde
creat
furinlik
cleavag
site
use
cellperm
gener
inhibitor
furinlik
pc
investig
potenti
involv
proteas
process
differenti
cell
infect
presenc
differ
concentr
decanoyl
furinlik
inhibitor
decrvkrcmk
hpi
protein
supernat
harvest
analyz
fig
expect
glycoprotein
refer
viru
cleav
fig
wherea
cleavag
protein
mutant
viru
inhibit
dosedepend
manner
decrvkrcmk
fig
evalu
whether
kinet
viral
replic
also
affect
supernat
harvest
period
hpi
evalu
infecti
viral
particl
reveal
signific
differ
fig
furinlik
inhibitor
reduc
cleavag
protein
variant
sought
identifi
proprotein
convertas
could
play
role
cleavag
glycoprotein
infect
shown
fig
synthet
peptid
contain
sequenc
refer
viru
rrsrg
cleav
recombin
furin
hour
like
hand
synthet
peptid
contain
sequenc
mutant
viru
rrsrr
cleav
minut
like
furin
less
three
addit
proprotein
convertas
much
less
effici
shown
proprotein
convertas
abl
cleav
viral
glycoprotein
vitro
sought
determin
whether
cleavag
could
associ
chang
viral
particl
morpholog
variant
compar
refer
rocatcc
observ
transmiss
electron
microscopi
tem
suggest
typic
coronaviru
doubl
crownshap
virion
present
two
differ
form
cell
supernat
harvest
hpi
infect
mix
primari
cn
cultur
balbc
mice
inde
fig
left
panel
repres
first
type
morpholog
name
long
long
peplom
measur
spike
hemagglutininesteras
peplom
shown
particl
right
panel
rel
length
protein
previous
determin
coronavirus
second
type
crown
morpholog
name
short
short
peplom
present
fig
short
morpholog
show
normal
peplom
similar
length
accur
character
spike
length
viral
particl
variant
measur
spike
length
equal
number
virion
viru
crown
present
long
long
short
short
peplom
fig
averag
length
spike
associ
long
type
crown
morpholog
nm
wherea
averag
length
spike
short
virion
nm
appar
averag
differ
nm
repres
reduct
total
length
spike
could
presum
play
role
viral
infect
therefor
next
count
number
viral
particl
long
short
crown
virus
fig
found
signific
differ
tend
demonstr
viral
particl
mutant
viru
mostli
short
state
compar
refer
viru
show
mainli
long
crown
given
variant
less
neurovirul
present
delay
dissemin
within
mous
cn
compar
rocatcc
refer
viru
two
observ
relat
differ
viral
infect
neuron
cell
sought
evalu
whether
correl
morpholog
differ
crown
viral
particl
fig
rel
infect
capac
infect
target
cell
signific
differ
found
ratio
infecti
viral
particl
total
viral
particl
evalu
number
viral
genom
present
viral
stock
use
experi
establish
variant
fig
furthermor
amount
viral
rna
associ
infect
cell
remain
period
hour
fig
suggest
attach
cell
entri
similar
virus
opportunist
pathogen
hcov
natur
neuroinvas
neurotrop
human
herein
make
use
cdna
infecti
clone
show
singl
nucleotid
polymorph
snp
natur
found
gene
known
contemporari
clinic
isol
lead
mutat
protein
without
significantli
affect
viru
neuroinvas
properti
infect
cell
cultur
howev
mutat
suffici
modifi
viral
spread
neurovirul
suscept
mice
modul
cleavag
protein
appear
relat
furinlik
activ
suscept
neuron
cell
even
though
mutant
harbor
snp
present
respiratori
clinic
isol
abl
detect
viral
presenc
respiratori
tract
infect
mice
studi
underway
tri
identifi
natur
occur
mutat
could
import
viral
spread
respiratori
tract
mice
nevertheless
result
indic
despit
differ
neurovirul
recombin
viru
retain
full
neuroinvas
properti
even
though
delay
viral
spread
product
infecti
viru
fig
phenomenon
may
part
explain
mutant
reduc
neurovirul
accompani
less
sever
neurolog
symptom
less
frequent
spread
spinal
cord
previous
report
protein
mutant
murin
coronaviru
mhv
virus
spread
region
brain
innat
immun
respons
well
establish
observ
astrogliosi
microgliosi
rout
infect
detect
viral
antigen
fig
stronger
astrogliosi
microgliosi
observ
infect
refer
viru
may
also
relat
faster
spread
throughout
cn
compar
mutant
viru
differ
viral
spread
confirm
primari
cultur
mous
brain
cell
variant
still
infect
neuron
primari
target
fig
even
though
astrocyt
could
also
infect
fig
agreement
previou
report
cultur
underlin
fact
chang
neurovirul
associ
chang
cell
tropism
previous
shown
mhv
could
rather
relat
modif
spread
infect
neuron
differenti
neurovirul
spread
could
certainli
consequ
mutat
protein
introduc
typic
furinlik
recognit
site
probabl
recogn
cellular
proprotein
convertas
pc
mutat
differ
found
whole
genom
recombin
virus
use
present
studi
proteolyt
cleavag
coronavirus
protein
character
sever
year
ago
murin
coronaviru
sinc
sever
report
indic
pc
appear
import
cellcel
fusion
andor
viru
entri
host
cell
transport
newli
assembl
virion
secretori
pathway
produc
cell
differ
coronavirus
includ
mhv
sarscov
fipv
data
present
fig
clearli
show
protein
harbor
mutat
easili
cleav
infect
cleav
version
protein
easili
detect
free
viru
present
cell
cultur
supernat
bare
detect
cellassoci
protein
taken
togeth
result
strongli
suggest
cleavag
take
place
late
step
infect
probabl
particl
assembl
egress
previous
shown
merscov
mhv
furthermor
cleavag
glycoprotein
also
impact
patholog
decreas
neurovirul
spread
within
cn
highli
interest
note
associ
decreas
virul
cleavag
coronaviru
glycoprotein
suggest
fcov
fact
coronavirus
includ
murin
mhv
bovin
coronaviru
bcov
clear
associ
establish
cleavag
virul
data
present
fig
strongli
suggest
pc
inde
involv
cleavag
protein
infect
neuron
cell
inhibit
furinlik
proteas
pc
alreadi
demonstr
coronavirus
like
merscov
mhv
type
inhibitor
result
support
observ
protein
refer
viru
rocatcc
fig
ratio
uncleav
protein
cleav
form
remain
equal
inhibitor
concentr
contrast
ratio
increas
mutant
viru
fig
dosedepend
manner
result
present
fig
bring
even
interest
new
inform
proteas
could
involv
actual
cleavag
inde
synthet
peptid
harbor
mutat
cleav
much
effici
pc
model
peptid
mimick
refer
viru
protein
furthermor
even
though
furin
repres
effici
convertas
much
lesser
extent
also
abl
cleav
synthet
peptid
could
therefor
cleav
protein
infect
suscept
cell
previous
shown
sarscov
inhibit
furinlik
activ
infect
human
neuron
cell
lead
us
suggest
pc
notabl
furin
cognat
proteas
involv
protein
cleavag
amino
acid
fig
number
morpholog
glycoprotein
virion
modul
infect
differ
rna
virus
harbor
class
fusion
protein
includ
coronavirus
case
appar
modif
crownshap
virion
fig
associ
observ
differenti
protein
cleavag
seem
increas
decreas
viral
infect
fig
moreov
inhibit
furinlikeact
influenc
capac
virus
enter
cell
fig
therefor
even
though
cleavag
associ
furinlik
activ
shown
influenc
viral
entri
ibv
protein
cleavag
pc
appear
modul
infect
shown
merscov
hand
modifi
virion
morpholog
associ
preferenti
cleavag
variant
protein
domain
interfac
correl
decreas
cn
viral
spread
neurovirul
suscept
mice
inde
delay
spread
primari
cultur
fig
within
cn
fig
observ
despit
effici
releas
infecti
particl
cell
cultur
medium
compar
refer
rocatcc
viru
relationship
may
seem
counterintuit
fact
reminisc
celltocel
mode
propag
prevail
grow
list
virus
exampl
famous
ineffici
spread
freeviru
particl
diffus
particl
remain
instead
associ
plasma
membran
product
transfer
toward
target
cell
occur
analog
tempt
specul
spike
cleavag
limit
amount
particl
plasma
membran
avail
celltocel
transfer
naiv
neuron
explain
differ
kinet
dissemin
virus
difficulti
mutant
reach
spinal
cord
even
though
dissemin
throughout
brain
hypothesi
may
appear
contradict
previous
document
posit
impact
spike
cleavag
mhv
sarscov
celltocel
transfer
occur
upon
fusiondepend
syncytium
format
furthermor
even
though
syncytium
format
upon
mhv
infect
often
link
cleavag
instanc
type
cellcel
fusion
shown
occur
without
cleavag
protein
strain
protein
cleav
without
abl
induc
syncytia
fact
regardless
cleavag
statu
protein
never
abl
induc
syncytia
type
cell
studi
therefor
tend
think
distinct
mutual
exclus
celltocel
propag
mechan
may
prevail
among
coronavirus
like
envelop
virus
especi
within
cn
cellcel
movement
virus
may
take
place
synaps
altogeth
observ
suggest
influenc
spike
cleavag
coronaviru
propag
absolut
prerequisit
therefor
per
se
predict
accur
effici
celltocel
spread
reason
underli
variabl
outcom
still
unclear
may
well
resid
differ
viru
receptor
structur
featur
attach
factor
exploit
coronavirus
given
expect
influenc
viru
spread
neurovirul
host
surviv
potenti
establish
cn
viral
persist
studi
inde
warrant
character
underli
mechan
associ
spread
within
cn
sdspage
fig
show
intermedi
size
fragment
migrat
uncleav
furinlik
cleav
form
protein
may
repres
unspecif
degrad
product
howev
analysi
protein
gene
sequenc
reveal
second
put
cleavag
site
amino
acid
kassr
function
second
put
cleavag
site
could
use
type
cell
proteas
includ
trypsin
tmprss
cathepsin
produc
fragment
molecular
weight
studi
character
possibl
involv
second
put
cleavag
site
identif
host
proteas
involv
potenti
process
protein
ongo
taken
togeth
result
current
studi
indic
first
time
clearli
abl
infect
neuron
cell
spread
without
need
furinlik
protein
cleavag
differ
viral
spread
within
cn
brain
primari
cultur
associ
increas
infecti
viral
particl
cultur
medium
viru
harbor
mutat
present
known
clinic
isol
well
absenc
modif
infect
two
virus
strongli
suggest
pcactivityassoci
cleavag
protein
play
import
role
egress
viral
bud
infect
cell
could
influenc
mode
viral
transmiss
cn
cell
import
better
understand
mechan
underli
viral
spread
within
cn
potenti
associ
adapt
particular
environ
even
though
refer
strain
highli
neurovirul
alreadi
shown
rna
persist
mous
cn
one
year
signific
proport
infect
mice
nevertheless
delay
dissemin
reduc
neurovirul
mutant
increas
host
surviv
therefor
could
favor
establish
cn
viral
persist
associ
potenti
viral
adapt
cn
environ
could
result
select
better
adapt
quasispeci
shown
mhv
end
persist
infect
human
cn
could
certain
circumst
associ
recurr
human
enceph
neurolog
degen
patholog
therefor
observ
hcov
natur
neuroinvas
mice
human
underlin
need
character
viral
cellular
determin
neuroinvas
properti
understand
mechan
consequ
viru
interact
nervou
system
essenti
better
understand
potenti
patholog
relev
consequ
design
diagnost
therapeut
strategi
includ
modul
host
proteas
proprotein
convertas
anim
experi
approv
institut
anim
care
use
ethic
committe
iacuc
institut
nation
de
la
recherch
scientifiqu
inr
conform
canadian
council
anim
care
ccac
anim
care
use
protocol
number
issu
iacuc
inr
anim
experi
describ
herein
wildtyp
refer
viru
obtain
american
type
cultur
collect
atcc
recombin
viru
rocatcc
gener
use
fulllength
cdna
clone
display
phenotyp
properti
wildtyp
viru
previous
describ
recombin
viru
use
refer
control
viru
experi
use
sitedirect
mutagenesi
stratagen
quikchang
multisitedirect
mutagenesi
kit
recommend
supplier
introduc
point
mutat
gene
code
spike
glycoprotein
nucleotid
correspond
amino
acid
chang
posit
correspond
recombin
viru
design
cdna
clone
transfect
cell
amplifi
two
passag
cell
line
sequenc
make
sure
introduc
mutat
present
mutat
appear
cell
line
gift
late
david
brian
univers
tennesse
cultur
minim
essenti
medium
alpha
memalpha
life
technolog
supplement
volvol
fetal
bovin
serum
fb
paa
ge
healthcar
use
produc
viral
stock
cell
line
kind
gift
stephan
ladisch
georg
washington
univers
school
medicin
cultur
rpmi
medium
supplement
volvol
fetal
bovin
serum
fb
mm
hepe
mm
sodium
pyruv
nonessenti
amino
acid
gibco
invitrogen
cell
differenti
human
neuron
previous
describ
briefli
cell
seed
cell
petri
dish
cell
rpmi
medium
supplement
volvol
fb
mm
hepe
mm
sodium
pyruv
nonessenti
amino
acid
next
day
everi
day
day
medium
replac
medium
supplement
volvol
fb
alltran
retino
acid
sigmaaldrich
infect
differenti
cell
petri
dish
plate
pretreat
furin
inhibitor
decanoylargvallysargchloromethylketon
decrvlrcmk
bachem
differ
concentr
h
medium
remov
cell
infect
defin
multipl
infect
moi
refer
mutant
viru
incub
h
without
furin
inhibitor
wash
pb
incub
fresh
rpmi
contain
decrvlrcmk
concentr
use
infect
hpi
supernat
cell
harvest
separ
protein
extract
evalu
infecti
viru
product
embryo
day
gestat
remov
pregnant
anesthet
mice
cortex
hippocampu
embryon
pup
brain
harvest
place
hank
balanc
salt
solut
hbss
medium
without
supplement
mm
sodium
pyruv
mm
hepe
buffer
tissu
incub
ml
hbsstrypsinedta
ratio
respect
min
gentl
tilt
mix
digest
tissu
wash
minut
three
time
hbss
medium
remov
replac
fresh
hbss
medium
without
supplement
mm
sodium
pyruv
mm
hepe
buffer
tissu
gentli
pipet
pasteur
pipett
dissoci
cell
decant
step
min
room
temperatur
supernat
transfer
ml
tube
ml
neurobas
medium
invitrogen
supplement
mm
glutamaxi
life
technolog
mm
hepe
buffer
supplement
life
technolog
gentamycin
volvol
hors
serum
life
technolog
step
perform
twice
increas
final
amount
cell
cell
seed
grown
collagenpolydlysin
final
concentr
treat
glass
coverslip
medium
replac
fresh
neurobas
medium
without
hors
medium
next
day
medium
chang
everi
day
cultur
readi
infect
day
cultur
cell
well
primari
mous
cn
cell
cultur
infect
defin
moi
mockinfect
incub
cell
line
primari
cultur
h
viru
adsorpt
incub
fresh
memalpha
supplement
volvol
fb
cell
fresh
neurobas
medium
primari
murin
cn
cell
cultur
fresh
rpmi
medium
supplement
volvol
fb
cell
differ
period
time
femal
balbc
mice
jackson
laboratori
age
day
postnat
dpn
dpn
inocul
respect
ic
rout
intranas
rout
tissu
cultur
infect
dose
recombin
viru
previous
describ
group
mice
infect
recombin
viru
observ
daili
basi
period
dpi
surviv
weight
variat
evalu
clinic
score
evalu
use
scale
distinct
level
equival
asymptomat
mous
mice
symptom
abnorm
flexion
four
limb
mice
present
social
isol
ruffl
fur
hunch
back
weight
loss
classifi
number
number
attribut
mice
moribund
state
dead
neurolog
scale
adapt
burrer
et
al
alreadi
publish
sever
virus
mous
brain
spinal
cord
tissu
cell
cultur
supernat
process
presenc
quantif
infecti
viru
indirect
immunoperoxidas
assay
ipa
cell
previous
describ
briefli
cell
incub
mous
primari
antibodi
dilut
detect
protein
three
pb
wash
cell
incub
secondari
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
antibodi
dilut
kirkegaard
perri
laboratori
final
immun
complex
detect
incub
wtvol
tetrahydrochlorid
sigmaaldrich
volvol
hydrogen
peroxid
pb
infecti
viru
titer
calcul
karber
method
previous
describ
immunohistochemistri
perfus
wtvol
paraformaldehyd
pfa
perform
five
infect
balbc
mice
recombin
viru
everi
day
dpi
sagitt
brain
section
prepar
thick
lancer
vibratom
serial
section
collect
incub
overnight
primari
antibodi
previous
describ
detect
viral
antigen
dilut
ascit
fluid
hybridoma
secret
murin
monoclon
antibodi
viral
n
protein
use
astrocyt
identifi
rabbit
antigli
fibrillari
acid
protein
antibodi
gfap
dako
dilut
activ
macrophagesmicroglia
rabbit
antiiba
wako
dilut
dayold
balbc
mice
rat
antimac
monoclon
antibodi
dilut
dayold
femal
balbc
mice
immunofluoresc
stain
primari
murin
cn
cell
cultur
wash
steril
pb
fix
wtvol
paraformaldehyd
min
room
temperatur
wash
cell
permeabil
methanol
min
sampl
incub
primari
antibodi
polyclon
rabbit
antigli
fibrillari
acid
protein
gfap
antibodi
dako
monoclon
mous
anti
protein
antibodi
hybridoma
supernat
fig
polyclon
rabbit
anti
protein
bovin
coronaviru
bcov
dilut
monoclon
mous
antimicrotubuleassoci
protein
antibodi
dilut
h
room
temperatur
three
wash
pb
cell
incub
dark
h
room
temperatur
secondari
fluoresc
antibodi
alexa
fluor
goat
antirabbit
life
technolog
alexa
fluor
antimous
life
technolog
three
pb
wash
tissu
section
incub
min
room
temperatur
phenylindol
dapi
life
technolog
wash
pb
water
mount
immunomount
mount
medium
fisher
scientif
immunohistochem
fluoresc
stain
observ
nikon
eclips
microscop
qimag
retigaexi
fast
digit
camera
use
procaptur
system
softwar
protein
cell
cultur
medium
cellassoci
protein
extract
use
ripa
buffer
mm
nacl
mm
tri
ph
vv
wv
sodium
deoxychol
mm
edta
supplement
proteas
cocktail
inhibitor
sigma
haltphosphatas
inhibitor
pierc
harvest
cell
pipet
ripa
buffer
incub
ice
min
centrifug
min
supernat
store
analyz
protein
concentr
determin
use
bca
protein
assay
kit
novagen
accord
manufactur
instruct
equal
amount
protein
subject
sdspage
use
criterion
gradient
gel
trisglycin
gradient
gel
transfer
pvdf
membran
semidri
transblot
apparatu
biorad
membran
block
overnight
tb
buffer
contain
vv
tween
tbst
wv
nonfat
milk
incub
monoclon
mous
anti
protein
antibodi
hybridoma
supernat
h
room
temperatur
three
wash
min
tbst
membran
incub
secondari
antimous
antibodi
coupl
horseradish
peroxidas
ge
life
scienc
detect
perform
use
enhanc
chemiluminesc
ecl
kit
biorad
use
kodakxomat
ls
film
kodak
observ
viral
particl
transmiss
electron
microscopi
tem
supernat
infect
mix
primari
cultur
murin
cn
ultracentrifug
nickel
grid
rpm
min
grid
dri
bibul
paper
neg
stain
min
drop
phosphotungst
acid
pta
real
time
rtpcr
absolut
quantit
viral
rna
genom
viral
stock
infect
cell
modifi
vijgen
collabor
use
taqman
technolog
use
crna
standard
gener
standard
curv
evalu
absolut
number
viral
genom
sampl
megashortscript
kit
ambionlif
technolog
briefli
total
rna
extract
qiazol
reagent
qiagen
cell
cultur
supernat
evalu
amount
viral
genom
viru
stock
qiagen
rneasi
mini
extract
kit
accord
manufactur
instruct
total
rna
extract
follow
infect
cell
hpi
crna
standard
construct
exactli
describ
elsewher
made
previous
describ
rna
concentr
evalu
sampl
quantifi
use
spectrophotomet
nanodrop
realtim
quantit
rtpcr
perform
taqmanrnatoct
kit
appli
biosystemslif
technolog
reaction
mixtur
taqman
rtpcr
mix
contain
rox
passiv
refer
dye
nm
forward
revers
primer
nm
fam
probe
four
extract
rna
supernat
sampl
crna
standard
serial
dilut
total
rna
cellassoci
cell
infect
use
reaction
amplif
detect
perform
steponeplu
realtim
pcr
system
apparatu
analysi
perform
stepon
softwar
version
appli
biosystem
synthet
peptid
vdysknrrsrgaittgi
sequenc
rocatcc
refer
viru
protein
amino
acid
vdysknrrsrraittgi
sequenc
viru
protein
amino
acid
made
inhous
laboratori
dr
robert
day
underlin
amino
acid
repres
polymorph
refer
clinic
isol
briefli
recombin
pc
enzym
first
titrat
use
decrvkrchloromethylketon
inhibitor
cleavag
assay
coronaviru
deriv
peptid
carri
nm
pc
bsa
final
volum
reaction
stop
tfa
final
hplc
analysi
acetonitril
gradient
min
done
quantif
obtain
peak
area
rel
min
peak
obatin
also
collect
identifi
use
malditof
cell
experi
statist
analysi
conduct
oneway
analysi
varianc
anova
follow
tukey
post
hoc
test
ttest
mice
experi
result
compar
use
two
nonparametr
statist
test
kruskalw
mannwhitney
surviv
rate
plot
surviv
curv
compar
use
log
rank
test
statist
signific
defin
p
